Urine Sediment Testing Market Report 2025

The urine sediment testing market size has grown strongly in recent years. It will grow from $1.91 trillion in 2024 to $2.04 trillion in 2025 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to advancements in laboratory practices, integration into clinical practice, educational initiatives and training, focus on nephrology and urology, standardization in testing protocols.

The urine sediment testing market size is expected to see strong growth in the next few years. It will grow to $2.83 trillion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to rising incidence of urinary tract disorders, integration of ai and machine learning, shift towards point-of-care testing, focus on preventive healthcare, development of personalized medicine. Major trends in the forecast period include enhanced quality control measures, remote monitoring and telemedicine, customization for specific disorders, development of ai-assisted analysis, focus on high-throughput screening.

The rising number of elderly individuals, defined as those aged 60 and above, is expected to fuel the growth of the urine sedimentation testing market. Urine sediment testing plays a crucial role in benefiting the aging population by identifying renal illnesses and providing valuable information on aggravating factors, prognosis, pathogenic bacteria, and antibiotic vulnerability. According to a factsheet published by the World Health Organization in October 2021, the global population of individuals aged 60 and above is projected to reach 1.4 billion by 2030, up from 1 billion in 2020. This demographic shift highlights the increasing demand for healthcare services, including diagnostic tests such as urine sedimentation testing, to cater to the health needs of the elderly population.

The increasing prevalence of chronic kidney diseases is anticipated to drive the growth of the urine sediment testing market in the future. Chronic kidney disease is characterized by the kidneys' diminished ability to filter blood effectively due to gradual damage and loss of function. Urine sediment testing is a straightforward and non-invasive procedure that provides valuable insights into kidney health, which can aid in diagnosing and monitoring chronic kidney disease (CKD). For example, in June 2023, a report from Kidney Research UK, a non-profit organization based in the UK, revealed that around 7.2 million individuals in the UK are living with chronic kidney disease, accounting for over 10% of the population. Among these, 3.25 million are in the advanced stages of the disease, while an additional 3.9 million are in the early stages. By 2033, the number of people affected by chronic kidney disease is expected to increase to 7.61 million. Thus, the rising prevalence of chronic kidney diseases is propelling the growth of the urine sediment testing market.

A prominent trend gaining traction is product innovation, with leading companies striving to introduce cutting-edge solutions to fortify their market positions. A notable example is Sysmex Corporation, a Japanese entity in this domain, which unveiled the UF-1500 Fully Automated Urine Particle Analyzer equipment in September 2022. This state-of-the-art apparatus offers distinct features, including an individualized view of diverse particles. The product is designed to provide a broader array of solutions tailored to customers' environments, facilitating standardization and scalability of urine testing, particularly in small and medium-sized facilities.

Major players in the urine sediment testing market are concentrating on the development of automated urinalysis systems to secure a competitive advantage. A urinalysis solution is a liquid utilized to test urine for various substances, including leukocytes (white blood cells), nitrites, protein, and glucose. For example, in October 2023, Beckman Coulter Inc., a US-based manufacturer of complex biomedical testing, introduced the DxU Iris Workcell. This fully automated urinalysis system streamlines workflows and reduces manual reviews to just 4%. The DxU Iris Workcell employs proprietary Digital Flow Morphology technology alongside Auto-Particle Recognition (APR) software to isolate, identify, and characterize urine particles on-screen, effectively eliminating the need for manual microscopy. Additionally, the DxU Iris Workcell is designed for ease of use and maintenance, featuring a user-friendly interface that requires minimal training for operation.

In May 2022, Beckman Coulter, a US-based firm, formed a partnership with Smart4Diagnostics to improve point-of-care testing solutions. This collaboration aims to merge Smart4Diagnostics’ innovative diagnostic technology with Beckman Coulter’s advanced laboratory equipment, thereby enhancing the efficiency and accuracy of diagnostic testing. The partnership emphasizes providing healthcare providers with rapid and reliable test results, ultimately leading to improved patient care. Smart4Diagnostics is a Germany-based manufacturer specializing in devices for blood and urine sample measurement.

Major companies operating in the urine sediment testing market include Abbott Laboratories, Siemens AG, Becton Dickinson and Company, F Hoffmann-La Roche Ltd., Sysmex Corporation, Beckman Coulter Inc., Thermo Fisher Scientific Inc., ARKRAY Inc., Mindray Medical International Limited, URIT Medical Electronic Co Ltd., 77 Elektronika Kft, ACON Laboratories Inc., Analyticon Biotechnologies AG, DIRUI Industrial Co. Ltd., HUMAN Gesellschaft für Biochemica und Diagnostica GmbH, Menarini Diagnostics, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., URIT Medical Electronic Group Co. Ltd., YD Diagnostics Corporation, Trinity Biotech plc, Quidel Corporation.

North America was the largest region in the urine sediment testing market in 2024. The regions covered in the urine sediment testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the urine sediment testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Urine sediment testing is a laboratory procedure used to analyze the physical components present in urine. It involves visually examining the urine, performing chemical analysis, and inspecting the urinary sediment under a microscope as part of qualitative urinalysis. The results obtained from this testing process contribute to diagnosing conditions and planning appropriate treatments.

The primary types of products used for urine sediment testing include fully automatic urine sediment analyzers and semi-automatic urine sediment analyzers. Fully automatic urine sediment analyzers are capable of storing clinical data, dry chemical indices, results from microscopic examinations, and other relevant information. They are utilized across various applications to detect urinary tract infections, diabetes, kidney diseases, hypertension, and other related conditions. These analyzers are employed by a range of end-users, including hospitals, diagnostics centers, clinics, ambulatory surgical centers, educational institutes, and similar healthcare facilities.

The urine sediment testing drugs market research report is one of a series of new reports that provides urine sediment testing drugs market statistics, including urine sediment testing drugs industry global market size, regional shares, competitors with a urine sediment testing drugs market share, detailed urine sediment testing drugs market segments, market trends and opportunities, and any further data you may need to thrive in the urine sediment testing drugs industry. This urine sediment testing drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The urine sediment testing market consists of sales of tubes, slides, urine sediment analyzer, and analytical kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.